News

October 9, 2015

Cancer treatments developed using animals have consistently had a high failure rate. Less than 8% of treatments that are effective in animal models show similar success in human clinical cancer trials.

September 25, 2015

In 2008 three major U.S. regulatory agencies announced the ground-breaking ToxCast initiative to reduce reliance on animals for chemical testing. Since then, the impetus to shift to non-animal test methods has continued to grow.

September 10, 2015

In recent months CAARE has shared news of advances in three-dimensional human cell cultures that are increasingly able to simulate the structure and function of real organs.

August 7, 2015

The promise of organ chips to revolutionize drug development while moving away from animals continues to expand.

July 23, 2015

Scientists have successfully created a model of early human heart development using stem cells derived from human skin cells. 

July 9, 2015

Dassault Systèmes announces the first virtual human heart.

June 11, 2015

As scientists learn more about the complexity of cancer, the need for personalized treatments based on the patient’s individual cancer has become increasingly pressing. 

May 21, 2015

In an unprecedented event, the European Parliament held a hearing last week to consider an initiative calling for an end to research on animals in the EU. 

May 7, 2015

Merck & Co., one of the world’s largest pharmaceutical companies, is teaming up with Organovo, a U.S. biotech firm specializing in manufacturing 3D printed tissues from human cells. The result, according to Organovo’s website, is “structurally and functionally accurate bioprinted human tissue models.”

April 17, 2015

The use of mice in biomedical research is coming under increasing fire for failing to model human disease. In March, The Guardian published an article (“Mice losing their allure as experimental subjects to study human disease”), which reinforced and strengthened the arguments against using mice.